Skip to content

Net margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
15%+3.8pp
Pfizer logo
PfizerPFE
15.7%
Immunome logo
ImmunomeIMNM
-5,593.8%-11,284pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-156.4%-47.5pp
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-111.9%-51.5pp
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-3,921.1%-4,562pp

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Calculated from Nuvation Bio’s reported figures.

Based on trailing twelve months.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's net margin?
Nuvation Bio (NUVB) reported net margin of -102.1% in Q1 2026.
How has Nuvation Bio's net margin changed year-over-year?
Nuvation Bio's net margin increased by 98.2% year-over-year, from -5,534.2% to -102.1%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.